DOI QR코드

DOI QR Code

Cancer Notification at a Referral Hospital of Kermanshah, Western Iran (2006-2009)

  • Rahimi, Zohreh (Medical Biology Research Center, Medical School, Kermanshah University of Medical Sciences) ;
  • Kasraei, Razieh (Medical Biology Research Center, Medical School, Kermanshah University of Medical Sciences) ;
  • Najafi, Farid (Research Center for Environmental Determinants of Health, School of Public Health, Kermanshah University of Medical Sciences) ;
  • Tanhapoor, Maryam (Department of Clinical Biochemistry, Medical School, Kermanshah University of Medical Sciences) ;
  • Abdi, Hamed (Department of Clinical Biochemistry, Medical School, Kermanshah University of Medical Sciences) ;
  • Rahimi, Ziba (Medical Biology Research Center, Medical School, Kermanshah University of Medical Sciences) ;
  • Vaisi-Raygani, Asad (Department of Clinical Biochemistry, Medical School, Kermanshah University of Medical Sciences) ;
  • Aznab, Mozafar (Department of Hematology Oncology, Medical School, Kermanshah University of Medical Sciences) ;
  • Moradi, Mahmoudreza (Department of Urology and Regenerative Medicine, Medical School, Kermanshah University of Medical Sciences)
  • Published : 2015.02.04

Abstract

Background: Cancer is a major public health problem and the leading cause of mortality in both males and females in developed and developing countries. The incidence of cancer is gender dependent. Among Iranians, it is the third cause of death. Materials and Methods: The information recorded in the files of all patients (7,695 individuals) pathologically diagnosed with cancer in Imam Reza referral hospital of Kermanshah University of Medical Sciences during the four year period of 2006-2009 were reviewed and analyzed using SPSS statistical software package version 16.0. Results: Around 61.6% of reported cancer cases were males and 38.4% were females. The most prevalent reported malignant tumors occurred at the age group of 70-79 years in males and in females these tumors were presented in the ages of 60-69 years. The most prevalent cancers among studied patients were gastrointestinal (GI) cancers with a frequency of 22.9% [gastric 10.7%, colorectal 6.9%, and esophageal 6%]. The second, third and forth prevalent cancers were blood at 16.4%, lung 13.5% and bladder 12.8%, respectively. In males the cancers of GI (25.6%) were the most prevalent followed in order of frequency by bladder (18%), blood (17.6%), lung (17.4%) and prostate (6.8%). In females the most frequent recorded cancer was breast (24.1%) followed in order of frequency by GI (20.5%), blood (14.4%), lung (7.3%), uterus (6.2%) and ovary (5.1%). Breast cancer was the most prevalent cancer (27%) in the age group of 40-49 years. Conclusions: The present study provides frequency data for various types of cancers in both males and females from a referral hospital of Kermanshah that are comparable with some reports from other areas of the country.

Keywords

Cancer distribution;GI tract;breast;blood;bladder;lung;Kermanshah, Western Iran

Acknowledgement

Supported by : Kermanshah University of Medical Sciences

References

  1. Alimoghaddam K, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in Tehran metropolis: The first report from the Tehran population-based cancer registry, 1998-2001. Arch Iran Med, 12, 15-23
  2. Alimoghaddam K, Jalali A, Sharifi Aliabadi L, et al (2014). The outcomes of esophageal and gastric cancer treatments in a retrospective study, single center experience. IJHOSCR, 8, 9-13.
  3. Atrkar-Roushan Z, Kazemnejad A, Mansour-Ghanaei F, Zayeri F (2013). Trend analysis of gastrointestinal cancer incidences in Guilan province: comparing rates over 15 years. Asian Pac J Cancer Prev, 14, 7587-93. https://doi.org/10.7314/APJCP.2013.14.12.7587
  4. Babaei M, Mousavi S, Malek M, et al (2005). Cancer occurrence in Semnan province, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev, 6, 159-64.
  5. Babu GR, Samari G, Cohen SP, et al (2011). Breast cancer screening among females in Iran and recommendations for improved practice: a review. Asian Pac J Cancer Prev, 12, 1647-55.
  6. Fateh M, Emamian MH (2013). Cancer incidence and trend analysis in Shahroud, Iran, 2000- 2010. Iran J Cancer Prev, 2, 85-94
  7. Harirchi I, Kolahdoozan S, Hajizadeh S, et al (2014). Esophageal cancer in Iran: a population-based study regarding adequacy of cancer surgery and overall survival. Eur J Surg Oncol, 40, 352-7. https://doi.org/10.1016/j.ejso.2013.10.011
  8. Kaviani A, Neishaboury MR, Mohammadzadeh N, Ansari-Damavandi M, Jamei K (2013). Effects of obesity on presentation of breast cancer, lymph node metastasis and patient survival: A retrospective review. Asian Pac J Cancer Prev, 15, 2225-9. https://doi.org/10.7314/APJCP.2013.14.4.2225
  9. Kolahdoozan S, Sajadi A, Radmard AR, Khademi H (2010). Five common cancers in Iran. Arch Iran Med, 13, 143-6.
  10. Mashhadi MA, Nezam K, Abdollahinejad MJ (2009). Gastric cancer in South East of Iran. IJHOSCR, 3, 38-42.
  11. Najafi F, Mozaffari HR, Karami M, et al (2011). Trends in incidence of gastrointestinal tract cancers in Western Iran, 1993-2007. Iran Red Crescent Med J, 13, 805-10.
  12. Rahimi Z, Merat A, Gerard N, Krishnamoorthy R, Nagel RL (2006). Implications of the genetic epidemiology of globin haplotypes linked to the sickle gene in Southern Iran. Hum Biol, 78, 719-31. https://doi.org/10.1353/hub.2007.0016
  13. Roshandel G, Sadjadi A, Aarabi M, et al (2012). Cancer incidence in Golestan province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med, 15, 196-200.
  14. Salehi A, Khezri A, Malekmakan L, Aminsharifi A (2011). Epidemiologic status of bladder cancer in Shiraz, Southern Iran. Asian Pac J Cancer Prev, 12, 1323-7.
  15. Somi MH, Farhang S, Mirinezhad SK, et al (2008). Cancer in East Azerbaijan, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev, 9, 327-30.
  16. Tahmasby B, MarnaniAB, Maleki M, et al (2013). Blood malignancies in Mazandaran province of Iran. Asian Pac J Cancer Prev, 14, 1053-6. https://doi.org/10.7314/APJCP.2013.14.2.1053
  17. Talaiezadeh A, Tabesh H, Sattari A, Ebrahimi S (2013). Cancer incidence in Southwest of Iran: first report from Khuzestan population-based cancer registry, 2002-2009. Asian Pac J Cancer Prev, 14, 7517-22. https://doi.org/10.7314/APJCP.2013.14.12.7517
  18. Yari K, Rahimi Z, Moradi MR, Rahimi Z (2014). The MMP-2-735 C allele is a risk factor for susceptibility to breast cancer. Asian Pac J Cancer Prev, 15, 6199-203. https://doi.org/10.7314/APJCP.2014.15.15.6199
  19. Yavari P, Sadrolhefazi B, Mohagheghi MA, Mehrazin R (2009). A descriptive retrospective study of bladder cancer at a hospital in Iran (1973-2003). Asian Pac J Cancer Prev, 10, 681-4.

Cited by

  1. iRGD as a tumor-penetrating peptide for cancer therapy vol.15, pp.5, 2017, https://doi.org/10.3892/mmr.2017.6419
  2. The GPX1 Pro198Leu polymorphism in gastric cancer patients with and without Helicobacter pylori infection vol.39, pp.11, 2017, https://doi.org/10.1007/s13258-017-0594-8